Get Started Free
Home›Healthcare›Medtronic
Medtronic logo
Medtronic
Healthcare

Medtronic Company Overview

Medtronic logo

Medtronic

● Active
Healthcare · Dublin, Ireland (operational HQ: Fridley, MN) · Est. 1949
Medical DevicesCardiacSurgical RoboticsNeuromodulation↗ Website
$108B
Valuation
$32.4B
Revenue
95k+
Employees
1949
Founded

Medtronic is the world's largest standalone medical device company, developing therapies and diagnostics across cardiac rhythm management, surgical robotics, neuromodulation, diabetes technology, and endoscopy. Its portfolio spans implantable cardiac monitors, transcatheter pacemakers, robotic surgery platforms, and closed-loop insulin delivery systems used in over 150 countries.

Recent Press
5 items
Press Release·2026-02-18
Medtronic Reports Strongest Revenue Quarter in 10 Years with $9B Q3 2026 Revenue
Medtronic reported Q3 fiscal 2026 revenue of $9 billion, its strongest quarterly growth in 10 quarters at 8.7% reported and 6% organic year-over-year, as pulsed field ablation revenue tracked to double to $2 billion by H1 fiscal 2027.
Product Launch·2026-02-17
Medtronic Hugo Robotic Surgery System Performs First U.S. Commercial Case at Cleveland Clinic
The first U.S. commercial surgical case using Medtronic's FDA-cleared Hugo robotic-assisted surgery system was performed at Cleveland Clinic on February 17, 2026, with the platform already available in 35+ countries and targeting gynecologic and general surgery expansion.
Product Launch·2026-02-13
Medtronic Receives FDA Clearance for Stealth AXiS Spine Surgery System
Medtronic received FDA clearance for the Stealth AXiS surgical system on February 13, 2026, a unified platform integrating planning, navigation, and robotics for spine surgery, expanding the company's surgical robotics presence beyond soft tissue procedures.
Acquisition·2025-09-15
Medtronic Acquires CathWorks for Up to $585M to Expand Cardiac AI Diagnostics
Medtronic exercised its option to acquire CathWorks for up to $585 million, gaining the FFRangio AI-driven angiography-based coronary physiology platform to strengthen its interventional cardiology diagnostics and treatment guidance portfolio.
Press Release·2025-05-20
Medtronic Announces Plans to Spin Off Diabetes Business as Independent MiniMed Company
Medtronic announced plans to spin off its diabetes business as a standalone company called MiniMed via a two-step IPO and split, with completion targeted by end of calendar 2026, creating a dedicated competitor to Dexcom, Insulet, and Tandem.
Company History
10 milestones
Earl Bakken and Palmer Hermundslie founded Medtronic in a 600-square-foot garage in Minneapolis, initially repairing medical equipment before pivoting to developing medical electronic products that would transform cardiovascular medicine.

Medtronic Organization Structure & Team

Org Chart
95,000 employees · Click a leader to explore their team
70,600 across 12 departments
Chief Executive Officer
Geoff Martha
Gary Corona — Departments
· 70600 people across 12 depts

Medtronic Financials, Revenue & Market Share

Annual Revenue
$32.4B
+4.5% vs prior year
YoY Growth
+4.5%
From $28.9B to $32.4B
Revenue / Employee
$341K
Annual revenue per full-time employee
Revenue Growth
2021
2022
2023
2024
2025
$28.9B
$31.7B
$31.2B
$32.4B
$32.4B
Market Share
Global Cardiac Rhythm Management
35%
share
Medtronic
35%
Abbott Laboratories
25%
Boston Scientific
23%
Biotronik
10%
Others
7%
$650B
TAM
$180B
SAM
$32.4B
SOM
Revenue Streams
Cardiovascular Portfolio39%
Neuroscience Portfolio28%
Medical Surgical Portfolio22%
Diabetes7%
Other & Corporate4%
Business Units
Cardiovascular Portfolio39%
The largest segment covering CRM devices (Micra AV2 leadless pacemakers, Azure pacemakers, Evoque TAVR, MitraClip) and vascular intervention products — growing organically at 5–6% annually driven by structural heart.
Neuroscience Portfolio28%
Spine (titanium implants, biologics), DBS (Percept PC with BrainSense technology), InterStim II sacral neuromodulation, and Inceptiv spinal cord stimulation — recovering from COVID-procedural backlog with 4–5% organic growth.
Medical Surgical Portfolio22%
Hugo RAS robotic surgery (the growth driver at +15% YoY), GI Genius AI endoscopy, EV1000 hemodynamic monitoring, and Nellcor pulse oximetry — Hugo expansion driving disproportionate investment and market share expectations.
Diabetes7%
MiniMed 780G with Simplera Sync CGM leads the automated insulin delivery market in Europe and is expanding in the U.S. post-FDA approval — the fastest-growing business unit at +12% organically in FY2025.

Medtronic Internal Tools & Processes

Internal Tools
12 departments
Cardiac Rhythm Management4800 people · 3 roles
Standards & Certifications
10 standards
Compliance frameworks, security audits, and quality certifications this company maintains.
Regulatory
FDA QSR (21 CFR Part 820)
Compliant
Medtronic's U.S. medical device manufacturing facilities operate under FDA Quality System Regulation (21 CFR Part 820), governing design controls, production processes, corrective actions, and complaint handling for Class II and Class III devices including pacemakers, insulin pumps, and surgical robots.
Quality
ISO 13485
Certified
Medtronic holds ISO 13485 certification across its global manufacturing network, providing the foundational quality management system framework for medical device design, production, and post-market surveillance — required for CE Mark and regulatory approval in over 60 countries.
Regulatory
EU MDR 2017/745
Compliant
Medtronic has completed EU Medical Device Regulation (MDR) transition for its CE-marked portfolio including Hugo RAS, Micra AV2, and MiniMed 780G, complying with the more stringent clinical evidence, UDI labeling, and post-market clinical follow-up requirements under the 2017 regulation.
Regulatory
IEC 62304
Compliant
Medtronic applies IEC 62304 software lifecycle process standards to all embedded and standalone software in its medical devices, including the MiniMed 780G algorithm, Hugo robotic control software, GI Genius AI inference engine, and Percept PC DBS programming software.
Privacy
HIPAA
Compliant
Medtronic's CareLink remote monitoring network, MyCareLink Heart app, and CareMessenger patient communication systems comply with HIPAA Privacy and Security Rules for the transmission and storage of protected cardiac health data from remote device monitoring sessions.
Safety
IEC 60601-1
Certified
Medtronic's electrically active implantable and bedside devices — including ICDs, CRT-D systems, patient monitors, and the MiniMed insulin pump — comply with IEC 60601-1 electrical safety and essential performance standards required for global market clearance.
Safety
ISO 14971
Compliant
Medtronic applies ISO 14971 medical device risk management throughout the product lifecycle — from design input through post-market surveillance — covering residual risk evaluation for high-consequence implantable devices such as the Micra leadless pacemaker and Hugo RAS robotic system.
Environmental
ISO 14001
Certified
Medtronic's major manufacturing facilities in Galway (Ireland), Tempe (AZ), and Northridge (CA) hold ISO 14001 environmental management system certification, supporting Medtronic's commitment to achieving carbon neutrality in its own operations by 2030.
Regulatory
Sunshine Act (Open Payments)
Compliant
Medtronic reports all payments to U.S. physicians and teaching hospitals — including consulting fees, speaker honoraria, and research grants — in the CMS Open Payments database annually, with internal compliance controls covering over $500M in annual HCP transfers of value.
Security
UL 2900 (Cybersecurity)
Compliant
Medtronic's network-connected medical devices — including the MiniMed 780G, CareLink network, and Hugo RAS — undergo cybersecurity testing per UL 2900 and FDA post-market cybersecurity guidance, following Medtronic's coordinated vulnerability disclosure program established after the Conexus wireless protocol security incident in 2019.

Medtronic Interview Preparation

Interview Prep
Role-specific interview questions and keywords. Select a department, then click any role to prepare.
Cardiac Rhythm Management· 3 roles

Medtronic Products & Competitors

Product Suite
5 products · select one to explore
Healthcare
Cardiac Device
Micra AV2 Transcatheter Pacemaker
The world's smallest pacemaker. No leads. No pocket.

Micra AV2 is a miniaturized, self-contained pacemaker that is implanted directly into the right ventricle via a femoral catheter — eliminating the surgical chest pocket, transvenous leads, and associated infection and lead-related complication risks of conventional pacemakers. At one-tenth the size of traditional devices, it delivers AV-synchronous pacing for up to 15 years and has been implanted in over 250,000 patients worldwide.

Use Cases
Implanting a leadless pacemaker in a patient with prior transvenous lead infections or limited venous access who requires permanent bradycardia pacingProviding AV-synchronous pacing using Micra AV2's accelerometer-based atrial sensing for a sick sinus syndrome patient with normal AV conduction who cannot tolerate a conventional pacemaker pocketFollowing a Micra AV2 patient remotely through CareLink without scheduled in-clinic programmer visits, reducing the burden of follow-up for elderly patients with limited mobility
No image
Key Customers
CC
Cleveland Clinic
JHH
Johns Hopkins Hospital
CSMC
Cedars-Sinai Medical Center
Competitive Intelligence
VSAbbott Aveir DR
THEM

Abbott's Aveir DR is a dual-chamber leadless pacemaker system using i2i wireless communication between separate right atrial and right ventricular Aveir devices, enabling physiologic dual-chamber pacing without leads or a subcutaneous pocket.

EDGE

Micra AV2 has 250,000+ implants worldwide versus Aveir's recently launched dual-chamber system, with a longer-established real-world safety record, 15-year longevity, and broader global commercial availability

VSBoston Scientific EMPOWER Leadless Pacemaker
THEM

Boston Scientific's EMPOWER Modular Pacing System is a leadless right ventricular pacemaker designed to pair with the EMBLEM S-ICD for a fully subcutaneous cardiac rhythm management system without transvenous leads.

EDGE

Micra AV2's dedicated AV synchrony algorithm and standalone AV-synchronous pacing capability without requiring a companion ICD device differentiate it in the single-device leadless pacing indication

VSConventional Transvenous Dual-Chamber Pacemaker
THEM

Traditional dual-chamber pacemakers (e.g., Medtronic Azure, Abbott Assurity) use surgically implanted subcutaneous pulse generators connected to right atrial and right ventricular transvenous leads, providing proven AV synchrony but with lead and pocket-related complication risks.

EDGE

Micra AV2 eliminates lead-related complications (fracture, dislodgement, infection) and chest pocket hematomas — the most common reasons for conventional pacemaker reoperations — while matching AV-synchronous pacing performance

Related Companies

Eli Lilly logo
Eli Lilly
Healthcare
Eli Lilly is a global pharmaceutical company that discovers, develops, and markets medicines across diabetes, oncology, immunology, and neuroscience. Its GLP-1 receptor agonist portfolio — Mounjaro (tirzepatide) for type 2 diabetes and Zepbound for obesity — drove record revenue growth and positioned Lilly as one of the world's most valuable pharmaceutical companies.
Agilent Technologies logo
Agilent Technologies
Healthcare
Agilent Technologies is a global leader in life sciences, diagnostics, and applied chemical analysis, providing instruments, software, services, and consumables for laboratories worldwide. Its customers include pharmaceutical companies, academic research institutions, environmental labs, and food safety organizations that rely on Agilent's measurement science for analysis, testing, and compliance workflows.
Abbott Laboratories logo
Abbott Laboratories
Healthcare
Abbott Laboratories is a global healthcare company that develops and manufactures medical devices, diagnostics, nutrition products, and branded generic pharmaceuticals. Its portfolio spans the FreeStyle Libre continuous glucose monitoring system — the world's most-used CGM — alongside cardiac devices, point-of-care diagnostics, and infant nutrition brands across 160 countries.
Thermo Fisher Scientific logo
Thermo Fisher Scientific
Healthcare
Thermo Fisher Scientific is the world's largest life sciences company, providing analytical instruments, reagents, consumables, software, and services for scientific research, bioprocessing, clinical diagnostics, and pharmaceutical manufacturing. With over $44B in annual revenue, Thermo Fisher serves pharmaceutical and biotech companies, academic research institutions, clinical laboratories, and government agencies with an unmatched portfolio spanning mass spectrometry, chromatography, cell culture, genetic analysis, and laboratory equipment.
Stryker Corporation logo
Stryker Corporation
Healthcare
Stryker is one of the world's leading medical technology companies, offering a broad portfolio of innovative products and services in orthopedics, medical and surgical equipment, and neurotechnology. The company serves surgeons, hospitals, and healthcare systems across 75 countries with products ranging from joint replacement implants and surgical robots to emergency medical equipment.
Johnson & Johnson logo
Johnson & Johnson
Healthcare
Johnson & Johnson is one of the world's largest healthcare companies, operating across two segments — Innovative Medicine, which develops and markets prescription pharmaceuticals for oncology, immunology, neuroscience, and cardiovascular diseases, and MedTech, which produces surgical robotics, orthopedics, cardiovascular devices, and vision care products. After spinning off its consumer health division as Kenvue in 2023, J&J focuses exclusively on innovative medicine and medical technology.